Literature DB >> 2541689

Identification and partial characterization of an adenosine(5')tetraphospho(5')adenosine hydrolase on intact bovine aortic endothelial cells.

A Ogilvie1, J Lüthje, U Pohl, R Busse.   

Abstract

The biologically active dinucleotides adenosine(5')tetraphospho(5')adenosine (Ap4A) and adenosine(5')-triphospho(5')adenosine (Ap3A), which are both releasable into the circulation from storage pools in thrombocytes, are catabolized by intact bovine aortic endothelial cells. 1. Compared with extracellular ATP and ADP, which are very rapidly hydrolysed, the degradation of Ap4A and Ap3A by endothelial ectohydrolases is relatively slow, resulting in a much longer half-life on the endothelial surface of the blood vessel. The products of hydrolysis are further degraded and finally taken up as adenosine. 2. Ap4A hydrolase has high affinity for its substrate (Km 10 microM). 3. ATP as well as AMP transiently accumulates in the extracellular fluid, suggesting an asymmetric split of Ap4A by the ectoenzyme. 4. Mg2+ or Mn2+ at millimolar concentration are needed for maximal activity; Zn2+ and Ca2+ are inhibitory. 5. The hydrolysis of Ap4A is retarded by other nucleotides, such as ATP and Ap3A, which are released from platelets simultaneously with Ap4A.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541689      PMCID: PMC1138477          DOI: 10.1042/bj2590097

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  32 in total

Review 1.  Nucleotide metabolism by endothelium.

Authors:  J D Pearson; J L Gordon
Journal:  Annu Rev Physiol       Date:  1985       Impact factor: 19.318

Review 2.  Extracellular ATP: effects, sources and fate.

Authors:  J L Gordon
Journal:  Biochem J       Date:  1986-01-15       Impact factor: 3.857

3.  The hydrolysis of extracellular adenine nucleotides by cultured endothelial cells from pig aorta. Feed-forward inhibition of adenosine production at the cell surface.

Authors:  E L Gordon; J D Pearson; L L Slakey
Journal:  J Biol Chem       Date:  1986-11-25       Impact factor: 5.157

4.  Effects of diadenosine triphosphate (Ap3A) and diadenosine tetraphosphate (Ap4A) on platelet aggregation in unfractionated human blood.

Authors:  J Lüthje; J Baringer; A Ogilvie
Journal:  Blut       Date:  1985-12

5.  Increased free calcium in endothelial cells under stimulation with adenine nucleotides.

Authors:  A Lückhoff; R Busse
Journal:  J Cell Physiol       Date:  1986-03       Impact factor: 6.384

6.  Unproportionally high concentrations of diadenosine triphosphate (Ap3A) and diadenosine tetraphosphate (Ap4A) in heavy platelets. Consequences for in vitro studies with human platelets.

Authors:  J Lüthje; D Miller; A Ogilvie
Journal:  Blut       Date:  1987-04

7.  P2-purinoceptors mediate both vasodilation (via the endothelium) and vasoconstriction of the isolated rat femoral artery.

Authors:  C Kennedy; D Delbro; G Burnstock
Journal:  Eur J Pharmacol       Date:  1985-01-02       Impact factor: 4.432

8.  Hydrolysis of diadenosine 5',5''-P',P''-triphosphate (Ap3A) by porcine aortic endothelial cells.

Authors:  S J Goldman; E L Gordon; L L Slakey
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

9.  Highly efficient induction of human platelet aggregation in heparinized platelet-rich plasma by diadenosine triphosphate (Ap3A).

Authors:  J Lüthje; J Baringer; A Ogilvie
Journal:  Thromb Haemost       Date:  1985-08-30       Impact factor: 5.249

10.  Investigation of the preferred Mg(II)-adenine-nucleotide complex at the active site of ectonucleotidases in intact vascular cells using phosphorothioate analogues of ADP and ATP.

Authors:  J D Pearson; N J Cusack
Journal:  Eur J Biochem       Date:  1985-09-02
View more
  8 in total

1.  D-myo-inositol 1,3,4,5-tetrakisphosphate releases Ca2+ from crude microsomes and enriched vesicular plasma membranes, but not from intracellular stores of permeabilized T-lymphocytes and monocytes.

Authors:  A H Guse; E Roth; F Emmrich
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

Review 2.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

3.  Diadenosine polyphosphates induce intracellular Ca2+ mobilization in human neutrophils via a pertussis toxin sensitive G-protein.

Authors:  L Gasmi; A G McLennan; S W Edwards
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

4.  Diadenosine polyphosphate hydrolase from presynaptic plasma membranes of Torpedo electric organ.

Authors:  J Mateo; P Rotllan; E Marti; I Gomez De Aranda; C Solsona; M T Miras-Portugal
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

5.  Possible role of diadenosine polyphosphates as modulators of cardiac sensory-motor neurotransmission in guinea-pigs.

Authors:  A Rubino; G Burnstock
Journal:  J Physiol       Date:  1996-09-01       Impact factor: 5.182

6.  NPP4 is a procoagulant enzyme on the surface of vascular endothelium.

Authors:  Ronald A Albright; William C Chang; Donna Robert; Deborah L Ornstein; Wenxiang Cao; Lynn Liu; Meredith E Redick; J Isaac Young; Enrique M De La Cruz; Demetrios T Braddock
Journal:  Blood       Date:  2012-09-20       Impact factor: 22.113

7.  Chemical modification of a functional arginine residue in diadenosine 5',5'''-P1,P4-tetraphosphate (Ap4A) phosphorylase I from Saccharomyces cerevisiae.

Authors:  A K Robinson; L D Barnes
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

8.  Molecular basis of purinergic signal metabolism by ectonucleotide pyrophosphatase/phosphodiesterases 4 and 1 and implications in stroke.

Authors:  Ronald A Albright; Deborah L Ornstein; Wenxiang Cao; William C Chang; Donna Robert; Martin Tehan; Denton Hoyer; Lynn Liu; Paul Stabach; Guangxiao Yang; Enrique M De La Cruz; Demetrios T Braddock
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.486

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.